Skip to content
Search

Latest Stories

People with bipolar disorder 6 times more likely to die prematurely: Study

They are twice as likely to die from physical illnesses like heart and/or respiratory diseases, or cancer, with alcohol being a major contributing factor

People with bipolar disorder 6 times more likely to die prematurely: Study

According to a recent study published in BMJ Mental Health, individuals with bipolar disorder face a significantly higher risk of premature death compared to those without the condition.

The research revealed that people with bipolar disorder are six times more likely to die prematurely from external causes, such as accidents, violence, and suicide.


Additionally, they are twice as likely to die from physical illnesses like heart and/or respiratory diseases, or cancer, with alcohol being a major contributing factor.

The Finnish population-based study, conducted by researchers from Niuvanniemi Hospital in Finland, along with institutes from Sweden and the UK, aimed to shed light on the reasons behind the heightened risk of premature death among individuals with bipolar disorder.

While it has been known that such individuals face an elevated risk, the specific role of physical illnesses in this context had remained unclear until now.

Bipolar disorder, also known as manic depression, is a mental health condition characterised by extreme mood swings that include periods of intense euphoria or mania and episodes of deep depression.

Individuals with bipolar disorder experience alternating cycles of high energy, hyperactivity, impulsivity, and elation during manic phases, followed by periods of low energy, sadness, hopelessness, and lack of interest or pleasure during depressive phases.

The shifts between these mood states can be intense and disruptive, impacting a person's ability to function in daily life.

For the study, researchers tracked 47,018 individuals with bipolar disorder, and monitored the participants over a period of 14 years (2004-2018).

The average age of the participants at the start of the study was 38 years, and the data was obtained from nationwide medical and social insurance registers. Of those identified, 57 per cent were women.

During the monitoring period, a total of 3,300 individuals with bipolar disorder (7 per cent) died, in contrast to 141,536 deaths observed in the general population without the condition.

The researchers calculated the heightened risk of death among those with bipolar disorder to be six times higher due to external causes and two times higher from physical illnesses.

The average age at the time of death among the participants was 50 years, and approximately two-thirds of the deaths occurred in men.

In the study, it was revealed that out of the 3,300 deaths recorded among individuals with bipolar disorder, 61 per cent (2027 deaths) were attributed to physical causes, while 39 per cent (1273 deaths) were externally caused.

Among the physically caused deaths, alcohol was identified as the leading factor, accounting for 29 per cent (595 deaths). Within this category, liver disease was responsible for nearly half of the deaths, followed by accidental alcohol poisoning and alcohol dependence.

The remaining physically caused deaths were attributed to various factors: heart disease and stroke accounted for 27 per cent, cancer for 22 per cent, respiratory disease for 4 per cent, diabetes for 2 per cent, and other causes for 15-16 per cent.

Regarding the externally caused deaths, suicide was the primary cause, making up 58 per cent of the total.

Within this group, almost half of the suicides were caused by the overdose of prescribed mental health medications, including those used for treating bipolar disorder.

"A balanced consideration between therapeutic response, potential serious long term somatic (physical) side effects of different medicines, and risk of cause-specific premature mortality is needed, especially in younger persons," the authors wrote in their paper.

"Targeting preventive interventions for substance abuse will likely reduce the mortality gap both due to external causes and somatic causes. Suicide prevention remains a priority, and better awareness of the risk of overdose and other poisonings is warranted," they said.

(With inputs from PTI)

More For You

The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Bella Hadid

Bella Hadid stuns at the Cannes Film Festival 2025 in a daring Saint Laurent black gown

Instagram/ Vogue France

Bella Hadid pushes Cannes 2025 dress code to the edge in a daring Saint Laurent black gown

Bella Hadid’s return to the Cannes Film Festival was anything but quiet. This year, the model showed up ready to challenge the red carpet rules without actually breaking them.

With new restrictions in place like no sheer fabrics, no visible nudity, no dramatic trains or bulky silhouettes, fashion-watchers wondered if Bella, known for her daring Cannes looks in the past, would tone it down. Instead, she found a clever way around the rules.

Keep ReadingShow less
FDA Urges Immediate Stop to Use of Recalled Eye Care Products

The FDA has categorised the recall as a Class II

iStock

Eye care products recalled across US over sterility concerns, FDA warns users to stop immediately

A nationwide recall of five eye care products has been issued in the United States after concerns were raised about their sterility and manufacturing standards. BRS Analytical Services, LLC, the manufacturer of the affected products, has urged consumers to stop using them immediately due to potential safety risks.

The recall, shared in a press release by healthcare distributor AvKARE, affects more than 1.8 million cartons of eye drops. The US Food and Drug Administration (FDA) identified multiple violations during a recent audit, including failures to meet Current Good Manufacturing Practice (CGMP) standards.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less
Global Nursing Inequality Exposed in New Report on Nurses Day

The WHO forecasts a continued reduction in the global nursing shortage

iStock

International Nurses Day: Report shows the poorest regions face 70% shortages of nurses

The global nursing workforce has grown by nearly two million over the past five years, yet major disparities in distribution continue to impede progress towards universal health coverage (UHC) and global health goals, according to the State of the World’s Nursing 2025 report released on 12 May by the World Health Organization (WHO), International Council of Nurses (ICN), and partners.

As of 2023, there are 29.8 million nurses worldwide, up from 27.9 million in 2018. The report also notes a decline in the global nursing shortage, from 6.2 million in 2020 to 5.8 million in 2023. However, the report cautions that the improvements are not evenly shared across regions and income levels, leaving many low- and middle-income countries struggling with persistent shortfalls.

Keep ReadingShow less